What to Write Down in the First Week After a Dose Increase

Five things: the date and the dose, appetite and meal completion, symptoms and the date they started, weight measured the same way, and anything that interrupted the routine. That is the whole list. The GLP-1 Dose & Symptom Record is built around exactly these five, already dated and laid out.

The reason to write them in that particular week is that the first week after a change is the week most likely to be asked about later. Nothing about it looks significant while it is happening. Its value shows up months afterward, on the day someone asks when this started.

1. Date and dose

The dose, written as a number, and the date it changed, written as a date.

The dose is the anchor every other observation is measured against. A symptom on day three of a new dose and a symptom in week six of a steady one are different observations. Without the date, they are the same sentence.

2. Appetite and meal completion

Not a rating out of ten. A plain sentence about whether meals are being finished.

A 6 does not explain itself. Read it in June, and there is no way to recover what it meant in April. "Finished about half of dinner, wasn't interested in lunch" means the same thing whenever it is read.

3. Symptoms and the date they started

Symptoms are worth recording, but the onset date is the part that does the work.

Whether nausea happened is the easy half. When it started — relative to a dose change, relative to a meal pattern, relative to a week when nothing changed at all — is what makes it interpretable. Gastrointestinal effects are described in the literature as commonly appearing during initiation and escalation and typically easing as a dose is held (Gorgojo-Martínez et al., 2023), which is useful context, and it becomes usable only when your own dates sit beside it. That is also why the honest question is how long side effects can last after an increase rather than how long they will.

4. Weight measured the same way

Same time of day, same day of the week, same conditions.

A Tuesday-morning number and a Saturday-evening number were taken under different conditions, so whatever separates them includes the conditions. They are not two points in one series; they are two measurements wearing the same units. An inconsistent weigh-in does not produce a noisier record — it produces a record that cannot be compared to itself. It is also why a number that stops moving is so hard to read without the surrounding dates.

5. Interruptions and unusual circumstances

The missed dose. The pharmacy delay. The trip. The illness. The week that did not look like the other weeks.

Interruptions look like exceptions rather than data, so they are the easiest category to leave out — and they are often what a strange stretch turns out to sit next to. A late refill can only be laid beside the week it affected if the late refill was written down.

Why five and not fifteen

A record only helps if it is still being kept. A short list is easier to keep than a long one, and a record with gaps cannot be compared across the gaps.

Five things, dated, written while they are still boring. That is the version still going when someone finally asks the question the whole thing was for. If a different question is the one you have, start here or browse the GLP-1 Observation Records.

Sources

Gorgojo-Martínez, J. J., Mezquita-Raya, P., Carretero-Gómez, J., Castro, A., Cebrián-Cuenca, A., de Torres-Sánchez, A., García-de-Lucas, M. D., Núñez, J., Obaya, J. C., Soler, M. J., Górriz, J. L., & Rubio-Herrera, M. Á. (2023). Clinical recommendations to manage gastrointestinal adverse events in patients treated with GLP-1 receptor agonists: A multidisciplinary expert consensus. Journal of Clinical Medicine, 12(1), 145.

Disclaimer

This article is educational and is about observation and recordkeeping. It is not medical advice, and it does not diagnose or treat any condition. Nothing here should be used to start, stop, change, or delay any treatment. Decisions about medication, dosing, and care belong to you and your prescriber. If something you are experiencing concerns you, or if symptoms are severe, worsening, or persistent, contact a qualified healthcare professional. Sacred Books publishes records for documenting what you observe. It does not interpret those observations for you.

Ozempic®, Wegovy®, Mounjaro®, and Zepbound® are registered trademarks of their respective manufacturers. Sacred Books, LLC is not affiliated with, sponsored by, or endorsed by these manufacturers.